rs180742508

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001160148.2(DDHD1):​c.1503+10A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00278 in 1,453,538 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0018 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0029 ( 4 hom. )

Consequence

DDHD1
NM_001160148.2 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.10

Publications

0 publications found
Variant links:
Genes affected
DDHD1 (HGNC:19714): (DDHD domain containing 1) This gene is a member of the intracellular phospholipase A1 gene family. The protein encoded by this gene preferentially hydrolyzes phosphatidic acid. It is a cytosolic protein with some mitochondrial localization, and is thought to be involved in the regulation of mitochondrial dynamics. Overexpression of this gene causes fragmentation of the tubular structures in mitochondria, while depletion of the gene results in mitochondrial tubule elongation. Deletion of this gene in male mice caused fertility defects, resulting from disruption in the organization of the mitochondria during spermiogenesis. In humans, mutations in this gene have been associated with hereditary spastic paraplegia (HSP), also known as Strumpell-Lorrain disease, or, familial spastic paraparesis (FSP). This inherited disorder is characterized by progressive weakness and spasticity of the legs. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]
DDHD1 Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary spastic paraplegia 28
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 14-53072587-T-A is Benign according to our data. Variant chr14-53072587-T-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 238598.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00179 (273/152178) while in subpopulation NFE AF = 0.00314 (213/67926). AF 95% confidence interval is 0.00279. There are 0 homozygotes in GnomAd4. There are 119 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001160148.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DDHD1
NM_001160148.2
MANE Select
c.1503+10A>T
intron
N/ANP_001153620.1
DDHD1
NM_001160147.2
c.1524+10A>T
intron
N/ANP_001153619.1
DDHD1
NM_030637.3
c.1503+10A>T
intron
N/ANP_085140.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DDHD1
ENST00000673822.2
MANE Select
c.1503+10A>T
intron
N/AENSP00000500986.2
DDHD1
ENST00000357758.3
TSL:1
c.1503+10A>T
intron
N/AENSP00000350401.3
DDHD1
ENST00000556027.5
TSL:1
n.2094+10A>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.00180
AC:
273
AN:
152060
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000434
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000328
Gnomad ASJ
AF:
0.00288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00254
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00314
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00280
AC:
609
AN:
217404
AF XY:
0.00281
show subpopulations
Gnomad AFR exome
AF:
0.000483
Gnomad AMR exome
AF:
0.000282
Gnomad ASJ exome
AF:
0.00204
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00213
Gnomad NFE exome
AF:
0.00511
Gnomad OTH exome
AF:
0.00157
GnomAD4 exome
AF:
0.00289
AC:
3761
AN:
1301360
Hom.:
4
Cov.:
18
AF XY:
0.00290
AC XY:
1863
AN XY:
643400
show subpopulations
African (AFR)
AF:
0.000370
AC:
11
AN:
29760
American (AMR)
AF:
0.000257
AC:
9
AN:
35022
Ashkenazi Jewish (ASJ)
AF:
0.00219
AC:
49
AN:
22330
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37574
South Asian (SAS)
AF:
0.00
AC:
0
AN:
63210
European-Finnish (FIN)
AF:
0.00286
AC:
141
AN:
49246
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5190
European-Non Finnish (NFE)
AF:
0.00341
AC:
3432
AN:
1005588
Other (OTH)
AF:
0.00223
AC:
119
AN:
53440
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
179
358
536
715
894
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
124
248
372
496
620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00179
AC:
273
AN:
152178
Hom.:
0
Cov.:
32
AF XY:
0.00160
AC XY:
119
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.000433
AC:
18
AN:
41572
American (AMR)
AF:
0.000328
AC:
5
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.00288
AC:
10
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00254
AC:
27
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00314
AC:
213
AN:
67926
Other (OTH)
AF:
0.00
AC:
0
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
16
32
49
65
81
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00108
Hom.:
0
Bravo
AF:
0.00168
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

ClinVar submissions as Germline

Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Hereditary spastic paraplegia 28 (1)
-
-
1
not provided (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
0.32
DANN
Benign
0.60
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs180742508; hg19: chr14-53539305; API